Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

PHASE3RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

May 11, 2025

Study Completion Date

June 11, 2025

Conditions

Allergic Rhinitis

Interventions

DRUG

Desloratadine / Betamethasone in fixed dose

1 tablet, once a day of 5 mg / 0.25 mg

DRUG

Desloratadine

1 tablet, once a day of 5 mg

Trial Locations (1)

RECRUITING

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors

lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY